Overview

PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

Status:
Not yet recruiting

Trial end date:
2028-01-04

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the safety of prasugrel monotherapy without aspirin versus 12-month dual antiplatelet therapy (DAPT) in patients with STEMI using platinum-chrome everolimus-eluting stent (PtCr-EES: SYNERGYTM).

Phase:

Phase 4

Details

Lead Sponsor:

Kindai University

Collaborator:

Boston Scientific Corporation

Treatments:

Aspirin